340B Drug Pricing Program
The First Circuit recognized that the district court’s decision halting the 340B Rebate Program was “careful and thorough”— and correct. The AHA remains pleased that these courts have put on hold this harmful program that would have a devastating effect on America’s most vulnerable patients and…
The 1st U.S. Circuit Court of Appeals Jan. 7 denied the government’s motion for a stay in a lawsuit filed by the AHA, the Maine Hospital Association and four safety-net health systems challenging the Department of Health and Human Services’ 340B Rebate Model Pilot Program. This means that the…
The United States Court of Appeals for the First Circuit today denied the government’s motion for a stay in a lawsuit filed by the AHA, the Maine Hospital Association, and four safety-net health systems challenging the 340B Rebate Model Pilot Program.
Door County Medical Center (DCMC) has been serving the people of Door and Kewaunee counties in Wisconsin for more than 80 years.
On behalf of our members — including safety-net hospitals serving rural and underserved communities — we are pleased with today’s decision. The court’s decision halts a rule that would have caused a devastating sea change in a 30-year-old program relied upon by hospitals that serve America’s most…
The U.S. District Court of Maine today granted a preliminary injunction blocking implementation of the Department of Health and Human Services 340B Rebate Model Pilot Program.
The U.S. District Court of Maine today granted a preliminary injunction blocking implementation of the Department of Health and Human Services 340B Rebate Model Pilot Program.
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.
AHA 340B Advocacy Alliance Bulletin - December 16, 2025.
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.